1)打過booster+被傳染過
2)打過booster+沒被傳染過 (nAb levels half of 1))
...
。。。
Conclusions
In summary, boosted VaxCCP neutralized more than 95% of SARS-CoV-2 Omicron BQ.1.1, BF.7, and XBB. Samples collected within a six-month window from boosted individuals without prior infection had half the nAb levels as VaxCCP specimens. Taken together, boosted VaxCCP could be a viable substitute for anti-SARS-CoV-2 mAbs for passive immunotherapy of IC patients. The researchers suggested revising guidelines to include boosted VaxCCP for COVID-19 treatment in IC patients.